Guggenheim Capital’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $411K | Sell |
|
|||||
|
2025
Q2 | $356K | Sell |
|
|||||
|
2025
Q1 | $360K | Buy |
|
|||||
|
2024
Q4 | $211K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $390K | Buy |
|
|||||
|
2024
Q1 | $349K | Sell |
|
|||||
|
2023
Q4 | $393K | Buy |
|
|||||
|
2023
Q3 | $351K | Buy |
|
|||||
|
2023
Q2 | $379K | Buy |
|
|||||
|
2023
Q1 | $348K | Buy |
|
|||||
|
2022
Q4 | $153K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $208K | Sell |
|
|||||
|
2021
Q3 | $469K | Buy |
|
|||||
|
2021
Q2 | $483K | Sell |
|
|||||
|
2021
Q1 | $479K | Sell |
|
|||||
|
2020
Q4 | $500K | Sell |
|
|||||
|
2020
Q3 | $447K | Buy |
|
|||||
|
2020
Q2 | $396K | Sell |
|
|||||
|
2020
Q1 | $460K | Buy |
|
|||||
|
2019
Q4 | $419K | Buy |
|
|||||
|
2019
Q3 | $252K | Sell |
|
|||||
|
2019
Q2 | $300K | Sell |
|
|||||
|
2019
Q1 | $306K | Sell |
|
|||||
|
2018
Q4 | $278K | Buy |
|
|||||
|
2018
Q3 | $291K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $371K | Sell |
|
|||||
|
2015
Q4 | $543K | Sell |
|
|||||
|
2015
Q3 | $620K | Sell |
|
|||||
|
2015
Q2 | $898K | Sell |
|
|||||
|
2015
Q1 | $913K | Sell |
|
|||||
|
2014
Q4 | $844K | Buy |
|
|||||
|
2014
Q3 | $587K | Buy |
|